Skip to main content
Top
Published in: BMC Nephrology 1/2023

Open Access 01-12-2023 | Glomerulonephritis | Case Report

Fibronectin glomerulopathy in a kidney allograft biopsy

Authors: Nathaniel Klair, Salman B. Mahmood, Rasha El-Rifai, Cynthia C. Nast, Lihong Bu, Adam Bregman

Published in: BMC Nephrology | Issue 1/2023

Login to get access

Abstract

Background

Fibronectin glomerulopathy is a rare genetic nephropathy with only a few cases of post-transplant recurrence being reported previously. We highlight a case that was initially misdiagnosed and emphasize the importance of full immunofluorescence and electron microscopy evaluation in allograft biopsies.

Case presentation

A 36-year-old male with a history of end-stage kidney disease secondary to biopsy-proven type 1 membranoproliferative glomerulonephritis (MPGN) status-post living unrelated donor kidney transplant 12 years prior, presented with increasing creatinine and proteinuria. Biopsy was performed and was consistent with fibronectin glomerulopathy. Subsequent genetic testing revealed an FN1 mutation, the primary gene associated with this condition.

Conclusions

Full histologic evaluation of the allograft biopsy corrected the diagnosis and additionally suggested that the patient's mother, who had expired in her 30s and had received a diagnosis of type 1 MPGN on autopsy, likely also had fibronectin glomerulopathy, enabling appropriate genetic counseling for the family.
Literature
1.
go back to reference Castelletti F, Donadelli R, Banterla F, Hildebrandt F, Zipfel PF, Bresin E, et al. Mutations in FN1 cause glomerulopathy with fibronectin deposits. Proc Natl Acad Sci U S A. 2008;105(7):2538–43.CrossRefPubMedPubMedCentral Castelletti F, Donadelli R, Banterla F, Hildebrandt F, Zipfel PF, Bresin E, et al. Mutations in FN1 cause glomerulopathy with fibronectin deposits. Proc Natl Acad Sci U S A. 2008;105(7):2538–43.CrossRefPubMedPubMedCentral
2.
go back to reference Gemperle O, Neuweiler J, Reutter FW, Hildebrandt F, Krapf R. Familial glomerulopathy with giant fibrillar (fibronectin-positive) deposits: 15-year follow-up in a large kindred. Am J Kidney Dis. 1996;28(5):668–75.CrossRefPubMed Gemperle O, Neuweiler J, Reutter FW, Hildebrandt F, Krapf R. Familial glomerulopathy with giant fibrillar (fibronectin-positive) deposits: 15-year follow-up in a large kindred. Am J Kidney Dis. 1996;28(5):668–75.CrossRefPubMed
3.
go back to reference Ohtsubo H, Okada T, Nozu K, Takaoka Y, Shono A, Asanuma K, et al. Identification of mutations in FN1 leading to glomerulopathy with fibronectin deposits. Pediatr Nephrol. 2016;31(9):1459–67.CrossRefPubMed Ohtsubo H, Okada T, Nozu K, Takaoka Y, Shono A, Asanuma K, et al. Identification of mutations in FN1 leading to glomerulopathy with fibronectin deposits. Pediatr Nephrol. 2016;31(9):1459–67.CrossRefPubMed
4.
go back to reference Dos Reis Monteiro MLG, Custódio FB, de Menezes Neves PDM, Ferreira FM, Watanabe EH, Lerário AM, et al. A novel single amino acid deletion impairs fibronectin function and causes familial glomerulopathy with fibronectin deposits: case report of a family. BMC Nephrol. 2019;20(1):322.CrossRefPubMedPubMedCentral Dos Reis Monteiro MLG, Custódio FB, de Menezes Neves PDM, Ferreira FM, Watanabe EH, Lerário AM, et al. A novel single amino acid deletion impairs fibronectin function and causes familial glomerulopathy with fibronectin deposits: case report of a family. BMC Nephrol. 2019;20(1):322.CrossRefPubMedPubMedCentral
5.
go back to reference Yong JL, Killingsworth MC, Spicer ST, Wu XJ. Fibronectin non-amyloid glomerulopathy. Int J Clin Exp Pathol. 2009;3(2):210–6.PubMedPubMedCentral Yong JL, Killingsworth MC, Spicer ST, Wu XJ. Fibronectin non-amyloid glomerulopathy. Int J Clin Exp Pathol. 2009;3(2):210–6.PubMedPubMedCentral
6.
go back to reference Azegami T, Hashiguchi A, Nakayama T, Hayashi K, Kanda T, Itoh H. Fibronectin Glomerulopathy confused with Glomerular Endothelial injury in a patient with Takotsubo Cardiomyopathy. Intern Med. 2022;61(13):2027–32.CrossRefPubMed Azegami T, Hashiguchi A, Nakayama T, Hayashi K, Kanda T, Itoh H. Fibronectin Glomerulopathy confused with Glomerular Endothelial injury in a patient with Takotsubo Cardiomyopathy. Intern Med. 2022;61(13):2027–32.CrossRefPubMed
8.
go back to reference Strøm EH, Banfi G, Krapf R, Abt AB, Mazzucco G, Monga G, et al. Glomerulopathy associated with predominant fibronectin deposits: a newly recognized hereditary disease. Kidney Int. 1995;48(1):163–70.CrossRefPubMed Strøm EH, Banfi G, Krapf R, Abt AB, Mazzucco G, Monga G, et al. Glomerulopathy associated with predominant fibronectin deposits: a newly recognized hereditary disease. Kidney Int. 1995;48(1):163–70.CrossRefPubMed
9.
go back to reference Nasr SH, Valeri AM, Cornell LD, Fidler ME, Sethi S, Leung N, et al. Fibrillary glomerulonephritis: a report of 66 cases from a single institution. Clin J Am Soc Nephrol. 2011;6(4):775–84.CrossRefPubMedPubMedCentral Nasr SH, Valeri AM, Cornell LD, Fidler ME, Sethi S, Leung N, et al. Fibrillary glomerulonephritis: a report of 66 cases from a single institution. Clin J Am Soc Nephrol. 2011;6(4):775–84.CrossRefPubMedPubMedCentral
10.
go back to reference Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis–a new look at an old entity. N Engl J Med. 2012;366(12):1119–31.CrossRefPubMed Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis–a new look at an old entity. N Engl J Med. 2012;366(12):1119–31.CrossRefPubMed
11.
go back to reference Gale DP, de Jorge EG, Cook HT, Martinez-Barricarte R, Hadjisavvas A, McLean AG, et al. Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis. Lancet. 2010;376(9743):794–801.CrossRefPubMedPubMedCentral Gale DP, de Jorge EG, Cook HT, Martinez-Barricarte R, Hadjisavvas A, McLean AG, et al. Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis. Lancet. 2010;376(9743):794–801.CrossRefPubMedPubMedCentral
12.
go back to reference Li C, Wen YB, Li H, Li MX, Li XW, Li XM. Fibronectin Glomerulopathy caused by the Y973C mutation in Fibronectin: a case report and literature review. Chin Med Sci J. 2018;33(1):60–3.CrossRefPubMed Li C, Wen YB, Li H, Li MX, Li XW, Li XM. Fibronectin Glomerulopathy caused by the Y973C mutation in Fibronectin: a case report and literature review. Chin Med Sci J. 2018;33(1):60–3.CrossRefPubMed
13.
go back to reference Lorenz EC, Sethi S, Leung N, Dispenzieri A, Fervenza FC, Cosio FG. Recurrent membranoproliferative glomerulonephritis after kidney transplantation. Kidney Int. 2010;77(8):721–8.CrossRefPubMed Lorenz EC, Sethi S, Leung N, Dispenzieri A, Fervenza FC, Cosio FG. Recurrent membranoproliferative glomerulonephritis after kidney transplantation. Kidney Int. 2010;77(8):721–8.CrossRefPubMed
14.
go back to reference Green H, Rahamimov R, Rozen-Zvi B, Pertzov B, Tobar A, Lichtenberg S, et al. Recurrent membranoproliferative glomerulonephritis type I after kidney transplantation: a 17-year single-center experience. Transplantation. 2015;99(6):1172–7.CrossRefPubMed Green H, Rahamimov R, Rozen-Zvi B, Pertzov B, Tobar A, Lichtenberg S, et al. Recurrent membranoproliferative glomerulonephritis type I after kidney transplantation: a 17-year single-center experience. Transplantation. 2015;99(6):1172–7.CrossRefPubMed
15.
go back to reference Otsuka Y, Takeda A, Horike K, Inaguma D, Goto N, Watarai Y, et al. A recurrent fibronectin glomerulopathy in a renal transplant patient: a case report. Clin Transplant. 2012;26(Suppl 24):58–63.CrossRefPubMed Otsuka Y, Takeda A, Horike K, Inaguma D, Goto N, Watarai Y, et al. A recurrent fibronectin glomerulopathy in a renal transplant patient: a case report. Clin Transplant. 2012;26(Suppl 24):58–63.CrossRefPubMed
16.
go back to reference Wei X, Wang X, Zhang R, Liang P, Liu B, Wang L, et al. Case report: recurrent deposition in renal allografts: a rare case of Fibronectin Glomerulopathy overlooked in native kidneys. Front Genet. 2022;13: 839703.CrossRefPubMedPubMedCentral Wei X, Wang X, Zhang R, Liang P, Liu B, Wang L, et al. Case report: recurrent deposition in renal allografts: a rare case of Fibronectin Glomerulopathy overlooked in native kidneys. Front Genet. 2022;13: 839703.CrossRefPubMedPubMedCentral
Metadata
Title
Fibronectin glomerulopathy in a kidney allograft biopsy
Authors
Nathaniel Klair
Salman B. Mahmood
Rasha El-Rifai
Cynthia C. Nast
Lihong Bu
Adam Bregman
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2023
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-023-03403-y

Other articles of this Issue 1/2023

BMC Nephrology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine